ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas.

Candace L. Haddox, Suzanne George, Scott M. Schuetze et al.|Journal of Clinical Oncology|2025

Cited by 1